LPL Financial’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.7K Sell
332,534
-39,200
-11% -$10.9K ﹤0.01% 6016
2026
Q1
$122K Buy
371,734
+12,817
+4% +$20.1K ﹤0.01% 5632
2025
Q4
$1.11M Buy
358,917
+220,591
+159% +$629K ﹤0.01% 3961
2025
Q3
$364K Buy
138,326
+71,326
+106% +$157K ﹤0.01% 4891
2025
Q2
$82.4K Buy
+67,000
New +$73.1K ﹤0.01% 5301

Other funds holding GOSS

LPL Financial's GOSS Position: Q2 2026 in Review

LPL Financial reduced its Gossamer Bio (GOSS) stake by 11% in Q2 2026, selling an estimated $10.9K and leaving 332,534 shares worth $54.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6016.

LPL Financial first reported a position in GOSS in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.11M in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • LPL Financial held 332,534 shares of Gossamer Bio worth $54.7K as of Q2 2026.
  • LPL Financial sold 39,200 Gossamer Bio shares in Q2 2026, an estimated $10.9K.
  • Gossamer Bio made up ﹤0.01% of LPL Financial's portfolio in Q2 2026, its #6016 holding.
  • LPL Financial first reported a position in Gossamer Bio in Q2 2025 and has held it in 5 quarters since.
  • LPL Financial's Gossamer Bio position peaked at $1.11M in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.